“…HepG2 cells, from a cell line that originated from human hepatoblastoma, were obtained from RIKEN Cell Bank (Tsukuba, Japan). HepG2‐GS‐3A4 cells, transduced with both hamster glutamine synthetase (GS) gene and human CYP3A4 gene, were established previously [8–10] . In short, pBudCE4 plasmid (Invitrogen, Carlsbad, CA, USA), which had two multi‐cloning sites with human cytomegalovirus gene and human elongation 1‐alpha subunit gene as promoters, was used for the vector after ligation with hamster Gs and human CYP3A4 genes; it was introduced by lipofection and positive clones were selected using the index of resistance against zeocin.…”